Private Health Plan “Grace Period” On Rx Out-Of-Pocket Limits Unfair, Patient Groups Argue
This article was originally published in The Pink Sheet Daily
Executive Summary
The federal government has indicated it is willing to allow group health plans to apply the Affordable Care Act’s new out-of-pocket spending limits to medical and pharmacy benefits separately during 2014, which could raise the cost threshold for patients with chronic conditions significantly, according to more than 100 patient groups.
You may also be interested in...
Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs
The agency’s projection that Medicare will spend $3.5bn on Leqembi in 2025 is nearly three times the level of sales that marketer Eisai is expecting for the drug in North and South America combined in its fiscal year 2026.
Biosimilar Substitution In Medicare Part D Formularies Mid-Year Established In Final Rule
Policy may be helpful in promoting acceptance of follow-ons in Medicare but is not expected to result in near-term savings to the program.
Xtandi Pricing and Patents: Alternatives To March-In Urged To Lower Medicare, Medicaid Costs
The timing of the request, with Xtandi’s loss of exclusivity on the horizon, could be explained by the concern that a change in the US presidential administration in 2025 may limit the prospects for near-term relief.